New drug research shows promising results in mice bred to develop the motor symptoms of Parkinson’s disease. A team in Finland finds that blocking an enzyme called prolyl oligopeptidase clears the mice’s brains of an accumulated protein that is a hallmark of Parkinson’s disease, halts further brain damage, and corrects movement impairment. While nobody knows...